Your browser doesn't support javascript.
loading
Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Khera, Nandita; Edwards, Marie Louise; Song, Yan; Sun, Rochelle; Manghani, Rocio; Shin, Heayoung; Simantov, Ronit; Signorovitch, James; Sivaraman, Smitha; Gergis, Usama.
Affiliation
  • Khera N; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.
  • Edwards ML; Analysis Group Inc., New York, NY, USA.
  • Song Y; Analysis Group Inc., Boston, MA, USA.
  • Sun R; Analysis Group Inc., Boston, MA, USA.
  • Manghani R; Gamida Cell Inc., Boston, MA, USA.
  • Shin H; Gamida Cell Inc., Boston, MA, USA.
  • Simantov R; Gamida Cell Inc., Boston, MA, USA.
  • Signorovitch J; Analysis Group Inc., Boston, MA, USA.
  • Sivaraman S; Gamida Cell Inc., Boston, MA, USA.
  • Gergis U; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu.
Adv Ther ; 41(7): 3013, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38762585

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2024 Document type: Article Affiliation country: Country of publication: